HURC 39.35 Hurco Companies $HURC Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
HURC 39.35 Hurco Companies $HURC Hit a 52 week high of 39.71 Currently at 39.35 +0.09 +0.23% With a day low of 39.00 and a total volume of 20,700.

HURC Hurco Companies Recent Headline News

30.5% Return Seen to Date on SmarTrend Hurco Cos Call (HURC)
Comtex SmarTrend(R) - Wed Oct 01, 4:42PM CDT
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on May 12th, 2014 at $27.47. In approximately 5 months, Hurco Cos has returned 30.47% as of today's recent price of $35.84.
HURC: 39.35 (+0.09)

Hurco Cos Shares Up 35.0% Since SmarTrend's Buy Recommendation (HURC)
Comtex SmarTrend(R) - Wed Sep 24, 10:58AM CDT
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on May 12th, 2014 at $27.47. In approximately 5 months, Hurco Cos has returned 35.02% as of today's recent price of $37.09.
HURC: 39.35 (+0.09)

Hurco Technology Draws Newcomers at the International Manufacturing Technology Show
GlobeNewswire - Tue Sep 23, 7:00AM CDT
Hurco Companies, Inc. (Nasdaq:HURC) reports that more than 70% of the visitors viewing the company's CNC technology in action at the International Manufacturing Technology Show (IMTS) in Chicago last week were first-time visitors. "The total visitor traffic to our booth and demonstrations, the number of new visitors, and the excitement surrounding Hurco's new technology/product introductions at IMTS exceeded our expectations," said Greg Volovic, President of Hurco.
HURC: 39.35 (+0.09)

Hurco Cos Up 36.5% Since SmarTrend Uptrend Call (HURC)
Comtex SmarTrend(R) - Wed Sep 17, 9:34AM CDT
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on May 12th, 2014 at $27.47. In approximately 4 months, Hurco Cos has returned 36.55% as of today's recent price of $37.51.
HURC: 39.35 (+0.09)

Hurco Cos Has Returned 28.6% Since SmarTrend Recommendation (HURC)
Comtex SmarTrend(R) - Wed Sep 10, 9:09AM CDT
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on May 12th, 2014 at $27.47. In approximately 4 months, Hurco Cos has returned 28.61% as of today's recent price of $35.33.
HURC: 39.35 (+0.09)

Hurco Companies, Inc. Announces Quarterly Cash Dividend
GlobeNewswire - Wed Sep 10, 7:09AM CDT
Hurco Companies, Inc. (Nasdaq:HURC), an international industrial technology company, announced today that its Board of Directors approved the payment of a cash dividend of $0.07 per share. The dividend will be paid on October 13, 2014, to shareholders of record as of the close of business on September 29, 2014.
HURC: 39.35 (+0.09)

Hurco Reports Third Quarter Results
GlobeNewswire - Fri Sep 05, 8:46AM CDT
Hurco Companies, Inc. (Nasdaq:HURC) today reported net income of $4,375,000, or $0.66 per diluted share, for its third fiscal quarter ended July 31, 2014, compared to $854,000, or $0.13 per diluted share, for the corresponding period in fiscal 2013. For the first nine months of fiscal 2014, Hurco reported net income of $10,280,000, or $1.56 per diluted share, compared to $6,291,000, or $0.96 per diluted share, for the corresponding period in fiscal 2013.
HURC: 39.35 (+0.09)

Hurco Cos Up 21.2% Since SmarTrend Uptrend Call (HURC)
Comtex SmarTrend(R) - Tue Sep 02, 9:46AM CDT
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on May 12th, 2014 at $27.47. In approximately 4 months, Hurco Cos has returned 21.22% as of today's recent price of $33.30.
HURC: 39.35 (+0.09)

Hurco Cos Up 15.9% Since SmarTrend Uptrend Call (HURC)
Comtex SmarTrend(R) - Fri Aug 15, 11:06AM CDT
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on May 12th, 2014 at $27.47. In approximately 3 months, Hurco Cos has returned 15.85% as of today's recent price of $31.83.
HURC: 39.35 (+0.09)

Shares of HURC Up 14.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 08, 9:53AM CDT
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on May 12th, 2014 at $27.47. In approximately 3 months, Hurco Cos has returned 14.31% as of today's recent price of $31.40.
HURC: 39.35 (+0.09)

Milestones, Financial Results and Conference Call Schedules, and Technical Updates - Research Reports on TriQuint, Tessera Technologies, Pixelworks, Enphase Energy and Hurco
PR Newswire - Thu Jul 24, 8:10AM CDT
Today, Analysts Review released its research reports regarding TriQuint Semiconductor, Inc. (NASDAQ: TQNT), Tessera Technologies Inc. (NASDAQ: TSRA), Pixelworks, Inc. (NASDAQ: PXLW), Enphase Energy, Inc. (NASDAQ: ENPH) and Hurco Companies Inc. (NASDAQ: HURC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5057-100free.
ENPH: 11.80 (+0.39), PXLW: 4.83 (+0.19), HURC: 39.35 (+0.09), TQNT: 22.07 (-0.82), TSRA: 31.56 (+0.15)

Hurco Is Working on a Potentially Disruptive 3D Printing Product
at The Street - Thu Jul 17, 2:38PM CDT
Move over 3D Systems and Stratasys. A 46-year-old Hurco has filed a U.S. patent for what may be disruptive technology that combines 3D printing with your basic CNC machine.
HURC: 39.35 (+0.09), DDD: 34.47 (-0.44), XONE: 20.90 (-0.46), SSYS: 103.07 (-3.26)

Why Hurco Companies (HURC) Stock Is Surging Today
at The Street - Tue Jul 15, 1:58PM CDT
Hurco Companies (HURC) stock is soaring after it announced filing a U.S. patent application for new technology it believes could turn a CNC milling machine into a 3D printer.
HURC: 39.35 (+0.09)

Hurco Files CNC-Based 3D Printing U.S. Patent Application
GlobeNewswire - Tue Jul 15, 7:22AM CDT
Hurco Companies, Inc. (Nasdaq:HURC) today announced the company recently filed a U.S. patent application for new technology combining 3D printing and CNC machining.
HURC: 39.35 (+0.09)

Hurco Names Sonja K. McClelland Vice President, Secretary, Treasurer and Chief Financial Officer
GlobeNewswire - Fri Mar 14, 7:00AM CDT
Hurco Companies, Inc. (Nasdaq:HURC)
HURC: 39.35 (+0.09)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading